Filter Results
:
(175)
Show Results For
-
All HBS Web
(175)
- People (1)
- News (53)
- Research (81)
- Events (3)
- Multimedia (9)
- Faculty Publications (48)
Show Results For
-
All HBS Web
(175)
- People (1)
- News (53)
- Research (81)
- Events (3)
- Multimedia (9)
- Faculty Publications (48)
- 01 Dec 2020
- News
Digital Health Care: Empowering Consumers
symptoms of diseases like diabetes or congestive heart failure. Before the implantable congestive heart failure monitor, for example, we had very poor diagnostic tools to alert the need for ASAP therapy, but these sensors can now alert providers when View Details
Keywords:
April White
- 31 Oct 2017
- First Look
New Research and Ideas, October 31, 2017
Potential of Patient-Reported Outcomes By: Rotenstein, Lisa, Robert S. Huckman, and Neil Wagle Abstract—No abstract available. Publisher's link: https://pubwww.hbs.edu/faculty/Pages/item.aspx?num=53372 forthcoming Clinical Pharmacology & View Details
Keywords:
by Sean Silverthorne
- 29 Apr 2016
- News
The First Five Years: Kelly McKenna (MBA 2015)
needed it. Listening to music is still very therapeutic for me. Seeing how art has helped our artists express themselves and heal has made me want to take on painting, too.” Which HBS course (or courses) had the most profound impact on...
View Details
- 13 Jun 2005
- Research & Ideas
From Turf Wars to Learning Curves: How Hospitals Adopt New Technology
substitutable and the physician groups associated with each moved into closer competition with each other. Where turf wars do seem to have more of an impact is in how aggressively a hospital supports its initial investment in a given View Details
- 23 Mar 2021
- Book
Succeeding in the New Work-from-Anywhere World
than fifty years, self-disclosure has been widely studied across a variety of interpersonal contexts, including friendships, romances, and therapeutic relations. The way to enhance trust between people is for all parties to self-disclose,...
View Details
Keywords:
by Michael Blanding
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
"But in order to determine that genetic information has a therapeutic use, we have to make a substantial investment—$350 to $500 million—in doing the clinical trial work. From a business standpoint, we need to protect our...
View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
significant published and implemented work in AI/algorithmic work already exists, we wanted to direct our interests to a therapeutic problem. The highly technical, image-related work of radiation oncology planning was highly suitable for...
View Details
- 01 Jun 2000
- News
The Business of Biotech
information has a therapeutic use, we have to make a substantial investment - $350 to $500 million - in doing the clinical trial work. From a business standpoint, we need to protect our investment." "High, upstream knowledge should not be...
View Details
Keywords:
Julia Hanna
- 14 May 2020
- Research & Ideas
What Leaders Can Do to Fight the COVID Fog
well (and no one is there to watch you). Exercise is also an area where individuals have a great deal of control, which makes it a therapeutic activity in times of uncertainty. Short-term bursts of strenuous activity are not only...
View Details
Keywords:
by Boris Groysberg and Robin Abrahams
- 20 Sep 2016
- First Look
September 20, 2016
since it was started, with no therapeutic product available in the foreseeable future, Kaplan is considering whether it is time to change the company's business model. Purchase this case:...
View Details
Keywords:
Sean Silverthorne
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
drugs (chemically-synthesized, “small-molecule” drugs) face price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already approved original...
View Details
Keywords:
Sean Silverthorne
- 11 Apr 2017
- First Look
First Look at New Research, April 11
treated with unproductive therapies while more easily uncovering therapeutic signals. However, such research initiatives alone will not deliver new medicines to patients in the absence of strong incentives to bring new products to market....
View Details
- Web
Annual Report 2019 - Annual Report 2019
healthcare providers caring for refugee patients. Sacerdote Runner-Up Award: Gramhal Post-harvest services of storage, credit, and market linkage for smallholder farmers. ALUMNI WINNERS Grand Prize: Blueland Eliminate weight and waste from everyday products. Runner-Up...
View Details
- 15 Jan 2019
- First Look
New Research and Ideas, January 15, 2019
forthcoming American Journal of Therapeutics Food and Drug Administration Guidance Documents and New Medical Devices: The Case of Breast Prostheses By: Weitzman, Rachel E., Ariel Dora Stern, and Daniel B. Kramer Abstract—No abstract...
View Details
Keywords:
Dina Gerdeman
- 08 Jun 2010
- First Look
First Look: June 8
uncertainty of commercial partners' interest in the therapeutic approach, and the constrained donor-based fundraising environment. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/610074-PDF-ENG Data.gov Karim R. Lakhani, Robert...
View Details
Keywords:
Martha Lagace
- 14 Aug 2018
- First Look
First Look at New Research and Ideas, August 14, 2018
decide how to bring Elyas on board, and ensure a robust strategy to maintain its leadership position in the region. Purchase this case: https://hbsp.harvard.edu/product/818022-PDF-ENG Harvard Business School Case 818-059 Spark Therapeutics: Pioneering Gene Therapy...
View Details
Keywords:
by Sean Silverthorne
- 01 Dec 2013
- News
Your Own Medicine
pharmaceutical company, developing their own drugs. His offer was simple. "Is your son on any treatment that is a direct result of what you have done?" he asked. "No," admitted Tracy. "I'm going to change that," Williams said. DART (Disease Action Research Therapy)...
View Details
- 09 Aug 2016
- First Look
August 9, 2016
drugs that have been shown to be therapeutically equivalent to an already approved original biologic drug—have only been approved in the United States since 2015. Europe has had biosimilar entry since 2006. This paper considers how...
View Details
Keywords:
Sean Silverthorne
- 01 Sep 2015
- First Look
First Look -- September 1, 2015
(TDABC) is an innovative costing tool in healthcare that can be used to directly compare the true cost of competing technologies over the full care cycle. Rather than only comparing therapeutic effectiveness over a limited number of...
View Details
Keywords:
Sean Silverthorne
- 17 Jun 2020
- News
Toronto Copes with COVID-19 Via Webinars; Alumni Respond to Pandemic in Philippines
Alumni Relations Boris Tsimerinov (PLDA16, 2017), the discussion focused on differences between the state of the COVID-19 crisis in Canada, the US, and the rest of the world. The webinar touched upon most recent clinical and therapeutic...
View Details
Keywords:
Margie Kelley